Stockreport

Zenas BioPharma Touts Phase 3 Win, But Stock Crashes [Yahoo! Finance]

Zenas BioPharma, Inc.  (ZBIO) 
PDF IgG4-RD is an immune system disorder where the body creates excess IgG4 antibodies, leading to inflammation and dense, tumor-like tissue growths (fibrosis) in multiple [Read more]